Neuspera Medical’s percutaneous sacral neuromodulation (pSNM) has hit the “gold standard”, with 84.2% of patients suffering ...

Levee Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted approval to initiate the ARID II (A Pivotal Study of VoRo UrologIc ScaffolD for the Treatment of Post ...

Valencia Technologies, a neuromodulation company focused on minimally invasive treatment of urgency urinary incontinence, announced the appointment of Richard W. Klauer as Vice President Sales. Mr.

Scientists worldwide are exploring the potential of devices dubbed electroceuticals to treat conditions from heart failure and asthma, to diabetes, incontinence, and arthritis. Produced by Alex Hogan ...

The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust CAGR of 27.5%, reaching US$1967.7 million in 2024 and an impressive US$8438.5 ...

AdaptHealth Corp's Q4 2024 results exceeded expectations with a 12.3% margin. See why trends in sleep apnea treatment make ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

The US medical device company’s Phase II pivotal clinical ... we believe the pSNM technology will establish a new standard in UUI therapy.” Elsewhere in the field of incontinence, FemPulse is set to ...

The Foley catheter market in China is poised for significant growth, with projections estimating a rise from USD 101.7 million in 2025 to USD 260.1 million by 2035, reflecting a robust CAGR of 9.8% ...

PITTSBURGH, PA, UNITED STATES, February 25, 2025 /EINPresswire / -- Lloyd K. Jackson Sr. of Bakersfield, CA is the creator of the Cat ...